Effects of body surface area-indexed calculations in the morbidly obese: a mathematical analysis

Adam C Adler1, Brian H Nathanson, Karthik Raghunathan

  • 1Department of Anesthesiology, Baystate Medical Center, Springfield, MA; Tufts University School of Medicine, Boston, MA.

Insights

Standard cardiac and stroke indices can be misleading in morbidly obese patients due to distorted body surface area (BSA) calculations. This may lead to inappropriate hemodynamic therapy decisions.

Area of Science:

  • Anesthesiology and Critical Care Medicine
  • Cardiovascular Physiology
  • Medical Statistics

Background:

  • Cardiac and stroke indices are vital for assessing circulation adequacy, particularly in cardiac anesthesia.
  • Conventional formulas for calculating indexed values may be inaccurate for morbidly obese patients.

Observation:

  • This study analyzed how different body surface area (BSA) formulas affect cardiac output (CO) and stroke volume (SV) indexing in simulated morbidly obese patients.
  • Significant variations in BSA calculations were observed across seven different formulas for extreme body types.

Findings:

  • BSA calculations using common formulas can misclassify normal CO and SV values as abnormal in morbidly obese individuals.
  • The choice of BSA formula substantially impacts the interpretation of hemodynamic parameters.

Implications:

  • Relying on indexed cardiac and stroke volumes may lead to overtreatment in morbidly obese patients.
  • Further research is needed to establish appropriate BSA calculation methods for patients with extreme body types.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Metabolic Rate01:25

Metabolic Rate

The human body is a powerhouse of energy, with every cell performing numerous functions that require energy. This energy production and consumption is measured by the metabolic rate, which quantifies the total heat generated by all the body's chemical reactions and mechanical work. This measurement helps to determine the rate of kilocalorie (kcal) consumption needed to fuel all ongoing activities.
The Basal Metabolic Rate (BMR) measures the energy expended at rest.
Several factors influence the...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...